Key Insights

Highlights

Treatment Research

1 treatments under study, led by Removal Or Leaving Of Laa Occluders

Research Leaders

20 sponsors active, led by Sandeep Kumar Goyal, Piedmont Heart Institute Buckhead, Atlanta, GA, USA

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT05014477UnknownPrimary

Therapy Strategies After LAA Occluder Device Embolization

Showing all 1 trials

Research Network

Common Treatments

  • Removal Or Leaving Of Laa Occluders1

Active Sponsors

  • Sandeep Kumar Goyal, Piedmont Heart Institute Buckhead, Atlanta, GA, USA1
  • Andrey Osadchiy, City Hospital #40, St. Petersburg, Russia1
  • Jung-Sun Kim, Yonsei University Hospital, Seoul, South Korea1
  • Jesper van der Pals, Lund University Hospital, Lund, Sweden.1
  • Carsten Skurk, Charité, Universitätsmedizin Berlin, Berlin, Germany1

Top Investigators

  • Sophie Eppinger1

    CardioVascular Center (CVC) Frankfurt, Seckbacher Landstraße 65, 60389 Frankfurt am Main, Hesse, Germany

Related Conditions

  • Risk Factors1
  • Therapy Strategies1
  • Device Embolisation1

Activity Timeline